Bristol-Myers Squibb (BMY) Approaches New Upside Target of $36.99
Shares of Bristol-Myers Squibb (NYSE:BMY) have bullishly opened above the pivot of $36.57 today and have reached the first resistance level of $36.76. Investors may be interested in a cross of the next upside pivot targets of $36.99 and $37.41.
Based on a current price of $36.92, Bristol-Myers Squibb is currently 2.7% above its average consensus analyst price target of $35.91. The stock should discover initial support at its 50-day moving average (MA) of $33.65 and subsequent support at its 200-day MA of $33.59.
In the past 52 weeks, shares of Bristol-Myers Squibb have traded between a low of $30.64 and a high of $36.97 and are now at $36.92, which is 21% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.8%.
SmarTrend recommended that subscribers consider buying shares of Bristol-Myers Squibb on January 10th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $33.90. Since that recommendation, shares of Bristol-Myers Squibb have risen 7.7%. We continue to monitor BMY for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: pivot alerts Bristol-Myers Squibb